ID   PA-1/6TG-r
AC   CVCL_3121
DR   cancercelllines; CVCL_3121
DR   JCRB; JCRB1052
DR   JCRB; NIHS0328
DR   Wikidata; Q54937332
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0328; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0479 ! PA-1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 20
//